Difficulty: Medium
Average Score: 76%
Practice
A 38-year-old man with third-degree burns on 40% of his body undergoes a debridement procedure in the operating room. Succinylcholine is used at supratherapeutic dose. On postoperative day 1, the patient's serum potassium is 7.3 mEq/L. What is the most likely source of this problem?
Correct answer
C
Rationale
The correct answer is C) Potassium release from intracellular stores. During a debridement procedure, especially in a patient with significant burns, there can be massive tissue trauma leading to potassium release from intracellular stores into the bloodstream. Succinylcholine, a depolarizing muscle relaxant used during surgery, can further exacerbate this by causing a transient hyperkalemic state due to its mechanism of action at the neuromuscular junction.
Option A) Iatrogenic overdose of intravenous fluids is incorrect because excessive IV fluids would typically lead to dilutional hypokalemia rather than hyperkalemia.
Option B) Medication reaction between HÔéé blocker and burn eschar is incorrect as it is unrelated to the patient's hyperkalemia.
Option D) Succinylcholine overdose is incorrect because while succinylcholine can cause hyperkalemia, it is more likely due to the potassium release from damaged tissues in this context.
Understanding the pathophysiology behind hyperkalemia in burn patients is crucial for healthcare providers managing such cases. Monitoring electrolyte levels and being aware of the effects of medications in these patients is essential for providing safe and effective care. It highlights the importance of tailoring pharmacological interventions based on individual patient factors and underlying pathophysiology.
Option A) Iatrogenic overdose of intravenous fluids is incorrect because excessive IV fluids would typically lead to dilutional hypokalemia rather than hyperkalemia.
Option B) Medication reaction between HÔéé blocker and burn eschar is incorrect as it is unrelated to the patient's hyperkalemia.
Option D) Succinylcholine overdose is incorrect because while succinylcholine can cause hyperkalemia, it is more likely due to the potassium release from damaged tissues in this context.
Understanding the pathophysiology behind hyperkalemia in burn patients is crucial for healthcare providers managing such cases. Monitoring electrolyte levels and being aware of the effects of medications in these patients is essential for providing safe and effective care. It highlights the importance of tailoring pharmacological interventions based on individual patient factors and underlying pathophysiology.